Sign Up to like & get
recommendations!
1
Published in 2021 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2021.1935872
Abstract: ABSTRACT Introduction: Angiogenesis is a vital process for cellular functions in both physiological and pathophysiological conditions and is one of the hallmarks of cancer progression and metastasis. VEGF/VEGFR-2 signaling pathway has been recognized as the…
read more here.
Keywords:
patent review;
review vegfr;
updated patent;
vegfr inhibitors ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2022.2012151
Abstract: ABSTRACT Introduction Tuberculosis (TB) caused by Mycobacterium tuberculosis (M.tb) has been a global challenge as 1.4 million deaths were reported in 2019, which included deaths attributed to HIV-TB co-infection. It is curable by the prescribed…
read more here.
Keywords:
review;
drug;
tuberculosis;
2018 present ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2023.2173573
Abstract: ABSTRACT Introduction Kidney-type glutaminase (GLS1), a key enzyme controlling the hydrolysis of glutamine to glutamate to resolve the ‘glutamine addiction’ of cancer cells, has been shown to play a central role in supporting cancer growth…
read more here.
Keywords:
gls1;
gls1 inhibitors;
updated patent;
patent review ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2023 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2023.2178299
Abstract: ABSTRACT Introduction The nuclear factor erythroid 2-related factor 2 (Nrf2) is a pivotal transcription factor that controls the expression of numerous cytoprotective genes and regulates cellular defense system against oxidative insults. Thus, activating the Nrf2…
read more here.
Keywords:
updated patent;
patent review;
nrf2 activators;
activators 2020 ... See more keywords